These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 7631393

  • 1. Transfusion of donor-type red cells as a single preparative treatment for bone marrow transplants with major ABO incompatibility.
    Nussbaumer W, Schwaighofer H, Gratwohl A, Kilga S, Schönitzer D, Nachbaur D, Niederwieser D.
    Transfusion; 1995 Jul; 35(7):592-5. PubMed ID: 7631393
    [Abstract] [Full Text] [Related]

  • 2. Pre-transplant donor-type red cell transfusion is a safe and effective strategy to reduce isohemagglutinin titers and prevent donor marrow infusion reactions in major ABO-mismatched transplants.
    Mehta P, Ramprakash S, Raghuram CP, Trivedi D, Dhanya R, Agarwal RK, Faulkner L.
    Ann Hematol; 2021 Aug; 100(8):2071-2078. PubMed ID: 34148110
    [Abstract] [Full Text] [Related]

  • 3. Donor-type red blood cell transfusion to deplete isoagglutinins prior to allogeneic stem cell transplantation from ABO major incompatible bone marrow donors.
    Jarisch A, Salzmann-Manrique E, Soerensen J, Sach G, Rettinger E, Willasch A, Bakhtiar S, Klarmann D, Bräuninger S, Moser L, Fekadu J, Hutter M, Klingebiel T, Klusmann JH, Bader P, Bonig H.
    Br J Haematol; 2023 Jun; 201(6):1159-1168. PubMed ID: 36949601
    [Abstract] [Full Text] [Related]

  • 4. Hemotherapy in patients undergoing blood group incompatible bone marrow transplantation.
    Lasky LC, Warkentin PI, Kersey JH, Ramsay NK, McGlave PB, McCullough J.
    Transfusion; 1983 Jun; 23(4):277-85. PubMed ID: 6410549
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. In vivo adsorption of isohemagglutinins with fresh frozen plasma in major ABO-incompatible bone marrow transplantation.
    Webb IJ, Soiffer RJ, Andersen JW, Cohen CA, Freeman A, Sugrue M, Ritz J, Anderson KC.
    Biol Blood Marrow Transplant; 1997 Nov; 3(5):267-72. PubMed ID: 9450922
    [Abstract] [Full Text] [Related]

  • 7. Hemolysis of transfused group O red blood cells in minor ABO-incompatible unrelated-donor bone marrow transplants in patients receiving cyclosporine without posttransplant methotrexate.
    Gajewski JL, Petz LD, Calhoun L, O'Rourke S, Landaw EM, Lyddane NR, Hunt LA, Schiller GJ, Ho WG, Champlin RE.
    Blood; 1992 Jun 01; 79(11):3076-85. PubMed ID: 1586749
    [Abstract] [Full Text] [Related]

  • 8. ABO-incompatible marrow transplants.
    Bensinger WI, Buckner CD, Thomas ED, Clift RA.
    Transplantation; 1982 Apr 01; 33(4):427-9. PubMed ID: 7041368
    [Abstract] [Full Text] [Related]

  • 9. Transplantation of ABO-incompatible bone marrow and peripheral blood stem cell components.
    Rowley SD, Liang PS, Ulz L.
    Bone Marrow Transplant; 2000 Oct 01; 26(7):749-57. PubMed ID: 11042656
    [Abstract] [Full Text] [Related]

  • 10. Transplantation of major ABO-incompatible bone marrow depleted of red cells by hydroxyethyl starch.
    Warkentin PI, Hilden JM, Kersey JH, Ramsay NK, McCullough J.
    Vox Sang; 1985 Oct 01; 48(2):89-104. PubMed ID: 2416122
    [Abstract] [Full Text] [Related]

  • 11. Safety and impact of donor-type red blood cell transfusion before allogeneic peripheral blood progenitor cell transplantation with major ABO mismatch.
    Scholl S, Klink A, Mügge LO, Schilling K, Höffken K, Sayer HG.
    Transfusion; 2005 Oct 01; 45(10):1676-83. PubMed ID: 16181220
    [Abstract] [Full Text] [Related]

  • 12. [Immunohematologic surveillance of patients treated with ABO incompatible bone marrow allografts].
    Mizon P, Jouet JP, Vanhaesbroucke C, Villard F, Wibaut B, Goudemand J.
    Transfus Clin Biol; 1994 Oct 01; 1(4):271-7. PubMed ID: 7921283
    [Abstract] [Full Text] [Related]

  • 13. Exchange transfusion the hard way: massive hemolysis following transplantation of bone marrow with minor ABO incompatibility.
    Greeno EW, Perry EH, Ilstrup SJ, Weisdorf DJ.
    Transfusion; 1996 Jan 01; 36(1):71-4. PubMed ID: 8607158
    [Abstract] [Full Text] [Related]

  • 14. ABO mismatch may affect engraftment in multiple myeloma patients receiving nonmyeloablative conditioning.
    Badros A, Tricot G, Toor A, Morris C, Guo C, Munshi N, Barlogie B, Cottler-Fox M.
    Transfusion; 2002 Feb 01; 42(2):205-9. PubMed ID: 11896336
    [Abstract] [Full Text] [Related]

  • 15. Impact of AB0-blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan Marrow Donor Program.
    Kimura F, Sato K, Kobayashi S, Ikeda T, Sao H, Okamoto S, Miyamura K, Mori S, Akiyama H, Hirokawa M, Ohto H, Ashida H, Motoyoshi K, Japan Marrow Donor Program.
    Haematologica; 2008 Nov 01; 93(11):1686-93. PubMed ID: 18835834
    [Abstract] [Full Text] [Related]

  • 16. Is ABO mismatch another risk factor for allogeneic hematopoietic stem cell transplantation in pediatric thalassemic patients?
    Atay D, Erbey F, Akcay A, Ozturk G.
    Pediatr Transplant; 2015 Sep 01; 19(6):645-51. PubMed ID: 26156679
    [Abstract] [Full Text] [Related]

  • 17. Serological complications of a major ABO incompatible bone marrow transplantation in a Polynesian with aplastic anemia.
    Ockelford PA, Hill RS, Nelson L, Blacklock HA, Woodfield DG, Matthews JR.
    Transfusion; 1982 Sep 01; 22(1):62-5. PubMed ID: 7039010
    [Abstract] [Full Text] [Related]

  • 18. A double buffy coat method for red cell removal from ABO-incompatible marrow.
    Rosenfeld CS, Tedrow H, Boegel F, Gremba C, Shadduck RK.
    Transfusion; 1989 Jun 01; 29(5):415-7. PubMed ID: 2660336
    [Abstract] [Full Text] [Related]

  • 19. Donor-type fresh frozen plasma is effective in preventing hemolytic reaction in major ABO incompatible allogeneic stem cell transplant.
    Quek J, Lee JJ, Lim FL, Diong C, Goh YT, Gopalakrishnan S, Ho A, Hwang W, Koh M, Loh Y, Linn YC.
    Transfusion; 2019 Jan 01; 59(1):335-339. PubMed ID: 30467850
    [Abstract] [Full Text] [Related]

  • 20. The impact of infused red blood cell volume on major and bidirectional ABO-mismatched bone marrow transplantation.
    Araújo AB, Schmalfuss T, Furlan JM, Speransa D, Angeli MH, Sekine L, Franz JPM.
    Cytotherapy; 2024 Oct 01; 26(10):1179-1184. PubMed ID: 38795114
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.